CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 20 of 48

Rheumatology (Oxford)

Briefs 761–800 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

  1. Rheumatology (Oxford)

    A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis

    Cohort studySystemic sclerosis

  2. Rheumatology (Oxford)

    Performance of spondyloarthritis-specific health utilities based on the ASAS Health Index: an ancillary analysis from the ASAS-HI validation study

    Secondary analysisSpondyloarthritis & PsA

  3. Rheumatology (Oxford)

    Foot peripheral sensory neuropathy: a frequent disabling manifestation in systemic sclerosis

    Cross-sectional studySystemic sclerosis

  4. Rheumatology (Oxford)

    Cross-trait GWAS in COVID-19 and systemic sclerosis reveals novel genes implicated in fibrotic and inflammation pathways

    Meta-analysisSystemic sclerosis

  5. Rheumatology (Oxford)

    A predictive model based on the gut microbiota improves the diagnostic effect in patients with rheumatoid arthritis

    Diagnostic or prognostic studyRA

  6. Rheumatology (Oxford)

    Barriers to and facilitators of sustaining a systemic lupus erythematosus (SLE) patient decision aid in regular rheumatology outpatient care in the USA

    Research articleLupus & APS

  7. Rheumatology (Oxford)

    Tofacitinib treatment for active dermatomyositis and anti-synthetase syndrome: a prospective cohort pilot study

    Cohort studyMyositis

  8. Rheumatology (Oxford)

    Development of START, a novel multimedia-based symptom appraisal tool for autoimmune rheumatic diseases

    Diagnostic or prognostic studyAcross diseases

  9. Rheumatology (Oxford)

    Imaging tests as predictors of progression to rheumatoid arthritis in clinically suspect arthralgia: a systematic review and meta-analysis

    Meta-analysisRA

  10. Rheumatology (Oxford)

    Predictive value of insulin resistance metabolic score for cardiovascular disease in Chinese arthritis patients: a prospective cohort study

    Cohort studyAcross diseases

  11. Rheumatology (Oxford)

    Efficacy and safety of first-line targeted synthetic DMARDs in rheumatoid arthritis patients with chronic kidney disease

    Cohort studyRA

  12. Rheumatology (Oxford)

    Incidence rates of tuberculosis and inflammatory bowel disease in patients with ankylosing spondylitis treated with biologics in Korea

    Cohort studySpondyloarthritis & PsA

  13. Rheumatology (Oxford)

    Off-label use of biologics in urticarial vasculitis: a European retrospective cohort study

    Cohort studyVasculitis & PMR

  14. Rheumatology (Oxford)

    Tissue degrading and remodelling molecules in giant cell arteritis

    Mechanistic studyVasculitis & PMR

  15. Rheumatology (Oxford)

    Circulating secretory component-containing anti-citrullinated protein antibodies prior to symptom onset in rheumatoid arthritis

    Case-control studyRA

  16. Rheumatology (Oxford)

    In clinical hand osteoarthritis research, self-reported pain questionnaires do not reflect the patient experience

    Secondary analysisOsteoarthritis

  17. Rheumatology (Oxford)

    Prediction of scleroderma renal crisis in patients of SSc: insight from the CRDC cohort study

    Cohort studySystemic sclerosis

  18. Rheumatology (Oxford)

    Distinct genetic risk loci between biopsy-proven renal and non-renal lupus: a 10-year longitudinal cohort

    Cohort studyLupus & APS

  19. Rheumatology (Oxford)

    The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still’s Disease Registry

    Cohort studyAutoinflammatory & rare

  20. Rheumatology (Oxford)

    Nomogram for predicting proliferative lupus nephritis in patients with low-level proteinuria

    Diagnostic or prognostic studyLupus & APS

  21. Rheumatology (Oxford)

    Anakinra improves retention rate of targeted treatments in Erdheim–Chester disease

    Cohort studyAutoinflammatory & rare

  22. Rheumatology (Oxford)

    The clinical characteristics and treatment outcomes of patients with systemic polyarteritis nodosa: a single-centre study from India

    Cohort studyVasculitis & PMR

  23. Rheumatology (Oxford)

    Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies

    Randomized controlled trialSpondyloarthritis & PsA

  24. Rheumatology (Oxford)

    Anti-C1q antibodies in IgG4-related disease are common and associated with renal involvement and cutaneous small-vessel vasculitis

    Cross-sectional studyAutoinflammatory & rare

  25. Rheumatology (Oxford)

    Clinical characteristics of primary SS– and overlap SS–associated pulmonary arterial hypertension: a multicentre retrospective study

    Cohort studySjögren's & overlap

  26. Rheumatology (Oxford)

    Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase

    Meta-analysisGout & crystals

  27. Rheumatology (Oxford)

    Differences in phenotypes, treatments, and outcomes of ANCA-associated vasculitis across Europe, Japan and the USA in 2020

    Cohort studyVasculitis & PMR

  28. Rheumatology (Oxford)

    Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort

    Cohort studySystemic sclerosis

  29. Rheumatology (Oxford)

    Muscle-specific miRNAs in plasma and skeletal muscle of patients with idiopathic inflammatory myopathy are modulated by disease and training

    Mechanistic studyMyositis

  30. Rheumatology (Oxford)

    Menopausal hormone therapy and the risk of systemic lupus erythematosus and systemic sclerosis: a population-based nested case-control study

    Case-control studyLupus & APS

  31. Rheumatology (Oxford)

    Optical spectral transmission to monitor disease activity in arthritis patients: longitudinal follow-up comparison with clinical parameters

    Diagnostic or prognostic studyRA

  32. Rheumatology (Oxford)

    Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

    Cross-sectional studySpondyloarthritis & PsA

  33. Rheumatology (Oxford)

    Circulating PD-1hi CXCR5– and CXCR5+ CD4 T cells are elevated in patients with newly diagnosed giant cell arteritis, and predict relapse

    Cohort studyVasculitis & PMR

  34. Rheumatology (Oxford)

    Tocilizumab and rituximab for systemic sclerosis interstitial lung disease: a real-world cohort analysis

    Cohort studySystemic sclerosis

  35. Rheumatology (Oxford)

    The impact of an online, lifestyle intervention programme on the lives of patients with a rheumatic and musculoskeletal disease: a pilot study

    Research articleAcross diseases

  36. Rheumatology (Oxford)

    Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis

    Cohort studyAutoinflammatory & rare

  37. Rheumatology (Oxford)

    Association of patient- and hospital-level predictors with patterns of initial treatment in patients with rheumatoid arthritis: findings from a national cohort study

    Cohort studyRA

  38. Rheumatology (Oxford)

    Predictors of rituximab efficacy in systemic sclerosis-associated interstitial lung disease: machine-learning analysis of the DESIRES trial

    Secondary analysisSystemic sclerosis

  39. Rheumatology (Oxford)

    Total-body positron emission tomography: a tool for systemic, quantitative evaluation of the inflammatory burden of psoriatic arthritis

    Cross-sectional studySpondyloarthritis & PsA

  40. Rheumatology (Oxford)

    Immune checkpoint inhibitors-associated vasculitis: a heterogeneous condition with possible severe disease course

    Cohort studyVasculitis & PMR

All 1,905 Briefs in ExploreShowing Briefs 761–800 of 1,905, newest first